Alliance for Clinical Trials in Oncology researchers explore innovative approaches to treat pts w/ #bladdercancer . For #NationalBladderCancerAwarenessMonth , we feature five bladder cancer trials currently open for enrollment. Visit: bit.ly/Bladder-Ca #NCI #NCTN #blcsm Bladder Cancer Advocacy Network World Bladder Cancer Patient Coalition

Join us in Chicago or online for the 2024 Alliance Spring Hybrid Group Meeting! Check out a few highlights and be sure to register - bit.ly/Alliance-Spr24 #NCI #NCTN #NCORP #CancerResearch Alliance for Clinical Trials in Oncology

Founded by world-leading immunologists Miriam Merad, MD, PhD, Sacha Gnjatic, Seunghee Kim-Schulze, & Erik Wambre, OCCAM Immune offers biobanking and cutting-edge tools tailored for discovering immune biomarkers for patient stratification and the etiology of immune-mediated diseases.

Congrats to our New York Section AUA Amer. Urol. Assn. leadership class graduates! Vannita 😷Chiang, MD, MBA Reza Mehrazin, MD Doreen E. Chung. We are so proud to have you represent our section!

Thanks to Amer. Urol. Assn. and the mentors for this great opportunity & congratulations to the entire class !

Thank you! Tremendous honor to give the Donald S. Coffey Lecture at SUO/SBUR #AUA2024

So proud of my fellow Uromigo!!

biorxiv.org/content/10.110…

Well deserved Tom Powles. Tom is a visionary who has helped changed the landscape of therapy for #BladderCancer & #kidneycancer with innovative thinking and at the same time pragmatism with #clincialtrials . Terrific to see him on this list. Brian Rini, MD Toni Choueiri, MD Matt Galsky…

The power of the cooperative groups! - Stephanie Berg
Alliance for Clinical Trials in Oncology Toni Choueiri, MD Tian Zhang, MD, MHS Dan George Michael Morris Matt Galsky Jonathan Rosenberg MD
oncodaily.com/56060.html

#ClinicalTrials #Cancer #GenitourinaryOncology #OncoDaily #Oncology

A +ve CHMP opinion for gem/cis + nivolumab (CheckMate -901 trial) today Michiel van der Heijden Matt Galsky #APCCC24 Likely to result in EMA approval. This will compete with maintenance avelumab due to ⬆️ RR & CR rate, but EV/pembro will follow soon I hope . news.bms.com/news/corporate…

We are happy to share our new study published today Journal of Clinical Oncology (👉 ascopubs.org/doi/10.1200/JC…) on the role of NECTIN4 amplifications to predict responses to Enfortumab Vedotin treatment in metastatic urothelial cancer.
With a huge contribution of our multinational team we uncovered…

Happy #ThankYouThursday to our incredible community of researchers, patients, and supporters! Your dedication to advancing cancer research through clinical trials is truly inspiring. Together, we are making a difference in the fight against cancer! #ClinicalTrials #Oncology #NCI

FIVE years while still staying relevant. Grit, more grit, and some more —-a journey like few others. Congrats to Alliance for Clinical Trials in Oncology investigators, Tian Zhang, MD, MHS as well as Dan George Michael Morris Matt Galsky Jonathan Rosenberg MD +stats team. Thank you to all the patients!

Tian: we…

Wow! Congrats to the A031704 team and all of the patients! 5 years in the making. The power of the cooperative groups! Tian Zhang, MD, MHS Toni Choueiri, MD Alliance for Clinical Trials in Oncology NCICancerTrials Atish Choudhury, MD PhD Alan Tan

Singapore Translational Cancer Consortium & Mount Sinai Hospital joining the IMCORE cancer research collaboration of 27 cancer centres & Roche. 96 cancer research project with >2000 scientists/HCPs and many high impact publications.Asian expansion reflects the global network

In my acceptance speech for the griffuel prize, I wore a silver dress to symbolize the “LIGHT” that science and advocates bring to humanity. I called on political leaders worldwide to be inspired by scientists’ commitment to a better and united world (1 out of 2)

Congratulations to our dear friend Rana for receiving the prestigious 2024 Christopher G. Wood Rising Star Award at the IKCS Europe, a well-earned recognition of her exceptional work in kidney cancer research! Your dedication and hard work have truly paid off. Cheers to your…

Congrats Miriam Merad, MD, PhD a 🌟! The Tisch Cancer Institute

1/ The long-awaited OS results from #KEYNOTE -564 are out NEJM! The 1st phase 3 trial to demonstrate a survival benefit for adjuvant treatment in #RCC .

nejm.org/doi/full/10.10…